APA

Anthuber M., Farkas S., Rihl M., Menger M. D., Schildberg F. W., Jauch K. W. & Messmer K. (19970320). Angiotensin-converting enzyme inhibition by enalapril: a novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. : Hepatology (Baltimore, Md.).

Chicago

Anthuber M, Farkas S, Rihl M, Menger M D, Schildberg F W, Jauch K W and Messmer K. 19970320. Angiotensin-converting enzyme inhibition by enalapril: a novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. : Hepatology (Baltimore, Md.).

Harvard

Anthuber M., Farkas S., Rihl M., Menger M. D., Schildberg F. W., Jauch K. W. and Messmer K. (19970320). Angiotensin-converting enzyme inhibition by enalapril: a novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. : Hepatology (Baltimore, Md.).

MLA

Anthuber M, Farkas S, Rihl M, Menger M D, Schildberg F W, Jauch K W and Messmer K. Angiotensin-converting enzyme inhibition by enalapril: a novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. : Hepatology (Baltimore, Md.). 19970320.